Search by Drug Name or NDC

    NDC 17312-0170-14 Chronic Fatigue Therapy 6; 3; 7; 3; 8; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 Details

    Chronic Fatigue Therapy 6; 3; 7; 3; 8; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1

    Chronic Fatigue Therapy is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN OTC DRUG category. It is labeled and distributed by TRP Company. The primary component is CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; GOLD; HELLEBORUS NIGER ROOT; PHOSPHORIC ACID; SCUTELLARIA LATERIFLORA; THUJA OCCIDENTALIS LEAFY TWIG.

    Product Information

    NDC 17312-0170
    Product ID 17312-170_751334b8-f21c-3f94-e053-2a91aa0a9bb9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Chronic Fatigue Therapy
    Proprietary Name Suffix n/a
    Non-Proprietary Name EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 6; 3; 7; 3; 8; 6; 6; 6; 6
    Active Ingredient Units [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
    Substance Name CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; GOLD; HELLEBORUS NIGER ROOT; PHOSPHORIC ACID; SCUTELLARIA LATERIFLORA; THUJA OCCIDENTALIS LEAFY TWIG
    Labeler Name TRP Company
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC],
    DEA Schedule n/a
    Marketing Category UNAPPROVED HOMEOPATHIC
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 17312-0170-14 (17312017014)

    NDC Package Code 17312-170-14
    Billing NDC 17312017014
    Package 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
    Marketing Start Date 2018-08-20
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 751334b8-f21b-3f94-e053-2a91aa0a9bb9 Details

    Revised: 8/2018